| Product ID |
Product Name |
CAS# |
Purity |
| Y3288060 |
Pomalidomide-C12-NH2 hydrochloride |
2862774-02-3 |
97% |
| Y3288279 |
Glutarimide-Isoindolinone-NH-PEG2-COOH |
2803827-03-2 |
98% |
| Y3253032 |
NAZ2329 |
2809469-05-2 |
99% |
| Y3293790 |
GRP-60367 hydrochloride |
2803211-60-9 |
99% |
| Y3258008 |
Glutarimide-Isoindolinone-NH-PEG3-COOH |
2803819-65-8 |
99% |
| Y3293562 |
TPC2-A1-P |
2804595-86-4 |
99% |
| Y3261483 |
Thalidomide-Propargyne-PEG1-COOH |
2828438-36-2 |
99% |
| Y3252616 |
FTI-2153 TFA |
2820151-01-5 |
99% |
| Y3257398 |
AST5902 trimesylate |
2929417-90-1 |
99% |
| Y3257138 |
UZH1a |
2813577-78-3 |
98% |
| Y3311772 |
Thalidomide-Propargyne-PEG2-COOH |
2797619-65-7 |
99.07% |
| Y3294577 |
UZH1 |
2925713-02-4 |
99% |
| Y3292162 |
HPK1-IN-3 |
2739844-34-7 |
99% |
| Y3295954 |
(Z)-Lanoconazole |
101529-65-1 |
99% |
| Y3261760 |
(+)-JQ-1-aldehyde |
2634778-37-1 |
98% |
| Y3294387 |
Ganaplacide hydrochloride |
2751586-94-2 |
97% |
| Y3287200 |
LY-411575 (isomer 2) |
2070009-70-8 |
99% |
| Y3257046 |
Tau protein (592-597), human TFA |
2703746-44-3 |
97% |
| Y3264153 |
ZM223 hydrochloride |
2438679-27-5 |
99% |
| Y3260142 |
Golotimod hydrochloride |
1029401-59-9 |
99% |
| Y3263926 |
D-Ala-Lys-AMCA hydrochloride |
2703746-41-0 |
98% |
| Y3288405 |
VHL Ligand 8 |
2701565-76-4 |
99% |
| Y3250811 |
2',3'-cGAMP sodium |
2734858-36-5 |
99% |
| Y3117853 |
2-(10-Bromo-9-anthracenyl)triphenylene |
1314562-66-7 |
98% |
| Y3294097 |
2-{[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl}-2-phenylacetamide |
2170136-02-2 |
99% |
| Y3270711 |
1-(3-bromopropyl)-4-(3-chlorophenyl)piperazinedihydrobromide |
2648956-74-3 |
95% |
| Y3260744 |
4-(1H-pyrazol-3-yl)pyridin-2-amine |
865605-08-9 |
95% |
| Y3272370 |
1-carbamimidamido-N-[2-(2-methylphenyl)ethyl]methanimidamidedihydrochloride |
2567497-39-4 |
95% |
| Y3268431 |
3-(pyridin-2-yl)piperidine-2,6-dione |
99071-79-1 |
95% |
| Y3265195 |
3-(2,2-difluorocyclopropyl)piperidinehydrochloride |
2098109-77-2 |
95% |
| Y3265196 |
2-[(4-hydroxy-2-methylphenyl)[(1Z)-2-methyl-4-oxocyclohexa-2,5-dien-1-ylidene]methyl]benzene-1-sulfonicacid |
412958-99-7 |
85% |
| Y3264172 |
2-amino-1-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]ethan-1-onehydrochloride |
2839156-21-5 |
95% |
| Y3269928 |
N-[(1-acetylpiperidin-3-yl)methyl]methanesulfonamide |
1281017-51-3 |
95% |
| Y3255576 |
2-amino-3-{1H-pyrrolo[2,3-c]pyridin-3-yl}propanoicaciddihydrochloride |
2825005-10-3 |
95% |
| Y3251000 |
6-(4-chlorophenyl)-2-methylimidazo[2,1-b][1,3]thiazole |
113991-24-5 |
95% |
| Y3261823 |
(9H-fluoren-9-yl)methyl4-[3-oxo-3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-spiro[2-benzofuran-1,9'-xanthen]-6'-yl]piperazine-1-carboxylate |
1041634-68-7 |
95% |
| Y3250733 |
1-{1,8-diazaspiro[4.5]decan-1-yl}-2-methylpropan-1-onehydrochloride |
2751615-35-5 |
95% |
| Y3255330 |
3-methyl-8-nitro-7-pentyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione |
203451-40-5 |
95% |
| Y3104698 |
2-(4H-1,2,4-triazol-3-yl)ethan-1-olhydrochloride |
2613388-66-0 |
95% |
| Y3104860 |
5-(furan-2-yl)-N-propyl-1,2-oxazole-3-carboxamide |
907989-92-8 |
95% |
| Y3104768 |
1,4-dioxa-9-azadispiro[4.2.4^{8}.2^{5}]tetradecane |
143040-01-1 |
95% |
| Y3104766 |
methyl4-{[(tert-butoxy)carbonyl]amino}-1-imino-1-oxo-1lambda6-thiane-4-carboxylate |
2378502-11-3 |
95% |
| Y3104762 |
methylimidazo[1,2-a]pyrimidine-7-carboxylatehydrochloride |
2253639-20-0 |
95% |
| Y3104770 |
3-chloro-4-(morpholin-4-yl)-1-[4-(trifluoromethyl)phenyl]-2,5-dihydro-1H-pyrrole-2,5-dione |
958732-63-3 |
95% |
| Y3104771 |
5-fluoro-3-hydroxy-3-[2-oxo-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]-2,3-dihydro-1H-indol-2-one |
1849580-17-1 |
95% |
| Y3104785 |
1-(cyclopropylcarbamoyl)ethyl3-[(3,4-dimethoxyphenyl)methylidene]-1H,2H,3H-cyclopenta[b]quinoline-9-carboxylate |
1096214-42-4 |
95% |
| Y3291065 |
2-[(3,3-difluorocyclobutyl)amino]-5-fluoro-N-(3-methylpent-1-yn-3-yl)pyridine-3-carboxamide |
1593886-16-8 |
95% |
| Y3104789 |
2,2-dimethyl-4-nitrobutanoicacid |
2167068-69-9 |
95% |
| Y3104931 |
N-[(1-ethyl-1H-pyrazol-5-yl)methyl]-4-methoxyaniline |
1006451-51-9 |
95% |
| Y3264456 |
N-{5-[(1E)-2-(4,4-difluorocyclohexyl)ethenyl]-6-methoxypyridin-3-yl}ethene-1-sulfonamide |
2412761-99-8 |
95% |
| Y3118144 |
5-(Aminomethyl)-3,3-dimethylbenzo[c][1,2]oxaborol-1(3H)-ol hydrochloride |
1393477-38-7 |
95%+ |
| Y3260759 |
(1R,4R,6S,15R,17R)-N-(cyclopropanesulfonyl)-17-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.0,4,6]octadec-7-ene-4-carboxamide |
1217263-04-1 |
95% |
| Y3248726 |
N-methyl-1-(1-methyl-1H-pyrazol-4-yl)piperidin-3-amine |
1340369-23-4 |
95% |
| Y3261441 |
5-fluoro-4-imino-3-methyl-1-(4-methylbenzenesulfonyl)-1,2,3,4-tetrahydropyrimidin-2-one |
1616664-98-2 |
95% |
| Y3270130 |
4-chloro-N-[2-(thiophen-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]benzamide |
1072089-45-2 |
98% |
| Y3271894 |
6-chloro-8-fluoro-5-nitroquinoline |
2866307-44-8 |
95% |
| Y3270079 |
rac-1-tert-butyl8-methyl(4R,8S)-1,6-diazaspiro[3.4]octane-1,8-dicarboxylatehydrochloride |
2918773-88-1 |
95% |
| Y3261999 |
2-(3-aminophenyl)-2-methylpropanoicacidhydrochloride |
103096-01-1 |
95% |
| Y3286790 |
3-(6-chloropyridin-3-yl)-N-[4-methyl-3-(pyridin-4-yl)-1H-pyrazol-5-yl]propanamide |
2665712-40-1 |
95% |
| Y3248676 |
rac-methyl(1s,3s)-1-(4-fluorophenyl)-3-hydroxycyclobutane-1-carboxylate,cis |
1462381-61-8 |
95% |
| Y3246198 |
4-chloro-N-[3-methyl-5-(2-phenylethynyl)pyridin-2-yl]-1-[(1s,4s)-4-acetamidocyclohexyl]-1H-pyrazole-5-carboxamide,cis |
2640753-29-1 |
95% |
| Y3254823 |
4-bromo-N-[(1Z,3E)-3-[(4-bromophenyl)imino]-2-methanesulfonylprop-1-en-1-yl]aniline |
2792737-80-3 |
95% |
| Y3306305 |
PMX 53 acetate(219639-75-5 free base) |
852629-88-0 |
99% |
| Y3305101 |
beta-Neoendorphin acetate(77739-21-0 free base) |
78658-39-6 |
99% |
| Y3308209 |
FC131 TFA (606968-52-9 free base) |
842166-42-1 |
99% |
| Y3308332 |
ACTH 11-24 acetate(4237-93-8 free base) |
79190-56-0 |
100% |
| Y3248040 |
(S)-Purvalanol B |
2310135-61-4 |
98% |
| Y3310430 |
4-[1-[4-[2-Hydroxy-3-[4-[1-methyl-1-[4-(2-oxiranylmethoxy)phenyl]ethyl]phenoxy]propoxy]phenyl]-1-methylethyl]-phenol |
194672-62-3 |
95% |
| Y3288544 |
BI-2493 |
2937344-16-4 |
98% |
| Y3297131 |
Ethyl 1-[3-(2-ethyl-1-piperidinyl)propyl]-5,5-di-(8Z)-8-heptadecen-1-yl-2,5-dihydro-1H-imidazole-2-carboxylate |
2412492-09-0 |
98% |
| Y3308368 |
EtS-DMAB |
2929446-76-2 |
99.16% |
| Y3291075 |
Msr-blue |
2966537-39-1 |
97% |
| Y3245342 |
Fast-TRFS |
2966536-18-3 |
97% |
| Y3287297 |
UZH1b |
2814392-17-9 |
99% |
| Y3289591 |
SAG dihydrochloride |
2702366-44-5 |
95% |
| Y3258730 |
Thalidomide-Piperazine-PEG2-COOH |
2797430-20-5 |
98% |
| Y3248875 |
Glutarimide-Isoindolinone-NH-PEG4-COOH |
2927334-86-7 |
99% |
| Y3294760 |
Thalidomide-Piperazine-PEG3-COOH |
2797619-63-5 |
99% |
| Y3248876 |
Thalidomide-Propargyne-PEG3-COOH |
2797649-54-6 |
98% |
| Y3316264 |
GAK inhibitor 49 hydrochloride |
2930378-91-7 |
99.52% |
| Y3296886 |
Thalidomide-PEG4-COOH |
2828438-28-2 |
95% |
| Y3311549 |
JMV 449 acetate |
141863-45-8 |
99.91% |
| Y3304732 |
PF-06305591 dihydrate |
2703582-76-5 |
99.92% |
| Y3287184 |
(S)-UFR2709 hydrochloride |
2934318-93-9 |
98% |
| Y3289766 |
LY-411575 (isomer 3) |
2070009-28-6 |
99% |
| Y3268513 |
Pifusertib hydrochloride |
2930090-28-9 |
98% |
| Y3287412 |
NiCur |
2674753-39-8 |
99% |
| Y3258027 |
GL0388 |
2886772-68-3 |
98% |
| Y3310140 |
PROTAC BRD9-binding moiety 1 hydrochloride |
2448414-41-1 |
98.07% |
| Y3250776 |
ZK824859 hydrochloride |
2436760-76-6 |
98% |
| Y3289950 |
Lenalidomide-C4-NH2 hydrochloride |
2435715-90-3 |
98% |
| Y3318328 |
MM-589 TFA |
2253167-09-6 |
98.67% |
| Y3268237 |
DTP3 TFA |
2759216-46-9 |
98% |
| Y3285883 |
AMG-548 dihydrochloride |
2518299-32-4 |
99% |
| Y3305400 |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) |
2918768-05-3 |
100% |
| Y3295619 |
(R)-NVS-ZP7-4 |
2517682-14-1 |
99% |
| Y3269095 |
m-PEG24-Mal |
2579693-28-8 |
95% |
| Y3248578 |
TCMDC-135051 hydrochloride |
2705545-47-5 |
98% |
| Y3268727 |
PROTAC BRD4 Degrader-5-CO-PEG3-N3 |
2704602-92-4 |
99% |
| Y3265795 |
Geldanamycin-FITC |
2969156-01-0 |
95% |